Trial · NCT07896720
Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study
NCT07896720, Not applicable, Not yet recruiting, Women's Hospital School Of Medicine Zhejiang University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study. Trials, record NCT07896720. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896720
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study
- NCT number
- NCT07896720
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 92 participants, estimated
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Conditions
- Endometrial Cancer, Cervical Cancer (Early Detection)
- Interventions
- MP2000 Thoracoabdominal Endoscopic Surgical System
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Surgical Success Rate | Perioperative | The proportion of participants who complete the planned surgical procedure without conversion to open surgery or other major intraoperative deviations. |
| Primary | Incidence of Grade 3 or Higher Complications | Up to 30 days after surgery | The proportion of participants who experience grade 3 or higher postoperative complications, as defined by the Clavien-Dindo classification. |
| Secondary | Overall Complication Rate | Up to 30 days after surgery | The proportion of participants who experience any postoperative complication, regardless of severity, including both surgical and medical complications. |
| Secondary | Operative Time (min) | Perioperative | The total duration of the surgical procedure, measured in minutes from skin incision to skin closure. |
| Secondary | Estimated Intraoperative Blood Loss (mL) | Perioperative | The estimated volume of blood lost during the surgical procedure, measured in milliliters. |
| Secondary | Positive Margin Rate (%) | Up to 30 days after surgery | The proportion of participants with positive surgical margins confirmed by postoperative pathological examination. |
| Secondary | Visual Analogue Scale (VAS) Pain Score | Postoperative Day 1 | The intensity of postoperative pain assessed using the Visual Analogue Scale (VAS). The scale ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain". Higher scores indicate a worse outcome. |
| Secondary | Surgeon Satisfaction Score | Perioperative | The level of satisfaction reported by the operating surgeon regarding the surgical system and procedure, assessed using a 5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied). Higher scores indicate a better outcome. |
| Secondary | Length of Hospital Stay (days) | Perioperative | The total number of days from admission to discharge after the surgical procedure. |
| Secondary | Transfusion Rate (%) | Perioperative | The proportion of participants who require blood transfusion during or after the surgical procedure. |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896720
GET https://conductscience.org/api/trials/v1/NCT07896720/registered